- Home
- ACTU vs EVG Comparison
ACTU vs EVG Comparison
Compare ACTU & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- EVG
- Stock Information
- Founded
- ACTU 2015
- EVG 2005
- Country
- ACTU United States
- EVG United States
- Employees
- ACTU N/A
- EVG N/A
- Industry
- ACTU
- EVG Investment Managers
- Sector
- ACTU
- EVG Finance
- Exchange
- ACTU NYSE
- EVG Nasdaq
- Market Cap
- ACTU 135.0M
- EVG 146.4M
- IPO Year
- ACTU 2024
- EVG N/A
- Fundamental
- Price
- ACTU $6.55
- EVG $11.13
- Analyst Decision
- ACTU Strong Buy
- EVG
- Analyst Count
- ACTU 1
- EVG 0
- Target Price
- ACTU $20.00
- EVG N/A
- AVG Volume (30 Days)
- ACTU 143.8K
- EVG 49.4K
- Earning Date
- ACTU 05-15-2025
- EVG 01-01-0001
- Dividend Yield
- ACTU N/A
- EVG 8.68%
- EPS Growth
- ACTU N/A
- EVG N/A
- EPS
- ACTU N/A
- EVG N/A
- Revenue
- ACTU N/A
- EVG N/A
- Revenue This Year
- ACTU N/A
- EVG N/A
- Revenue Next Year
- ACTU N/A
- EVG N/A
- P/E Ratio
- ACTU N/A
- EVG N/A
- Revenue Growth
- ACTU N/A
- EVG N/A
- 52 Week Low
- ACTU $5.50
- EVG $9.13
- 52 Week High
- ACTU $11.99
- EVG $10.86
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- EVG 72.73
- Support Level
- ACTU N/A
- EVG $10.80
- Resistance Level
- ACTU N/A
- EVG $11.14
- Average True Range (ATR)
- ACTU 0.00
- EVG 0.10
- MACD
- ACTU 0.00
- EVG 0.03
- Stochastic Oscillator
- ACTU 0.00
- EVG 95.28
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.